Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database-Reference-Cited by-同舟云学术

Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database

Published:2019-01-18 Issue:2 Volume:8 Page:515-526
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lin Qiuyan¹^ORCID,Huang Xiaoquan²,Zhong Canmei¹,Luo Tiancheng²,Zeng Xiaoqing²,Chen Shiyao²

Affiliation:

1. Department of Gastroenterology, Union Hospital; Fujian Medical University; Fuzhou China

2. Department of Gastroenterology, Zhongshan Hospital; Fudan University; Shanghai China

Funder

the 3-year Action Program of Shanghai Municipality for Strengthening the Construction of Public Health System

the Foundation of Discipline Construction of Evidence-based Medicine Center, Zhongshan Hospital, China

Youth of shanghai Municipal Commission of Health and Family Planning

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1937/fullpdf

Reference39 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

3. Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment;Chen;Hepatology,2014

4. Vascular invasion leaves its mark in hepatocellular carcinoma;Marshall;J Hepatol,2011

5. Liver resection with thrombectomy as a treatment of hepatocellular carcinoma with major vascular invasion: results from a retrospective multicentric study;Pesi;Am J Surg,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study;BMC Cancer;2024-04-16

2. The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial;Frontiers in Immunology;2023-10-24

3. Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study;Journal of Hepatocellular Carcinoma;2023-09

4. Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study;Translational Cancer Research;2023-01

5. Impact of marital status on overall survival in patients with early-stage hepatocellular carcinoma;Scientific Reports;2022-11-19